BACKGROUND: The purpose of this study was to compare longitudinal trajectories of maximal aerobic capacity in children with sickle cell anemia (SCA) and matched healthy controls, and explore whether these trajectories were associated with selected physiologic variables. PROCEDURE: Children with SCA (n = 33) and healthy controls (n = 30) matched at baseline for race, sex, Tanner stage, height, and weight completed three consecutive annual fitness assessments (VO2peak ). Data were compared between the groups at each time point and within groups over time. Change in VO2peak between the two groups over time was assessed using a linear mixed model with age, sex, fat-free mass (FFM), Tanner stage, and hemoglobin (Hgb) concentration as covariates. RESULTS: At baseline, children with SCA had significantly lower Hgb concentration (8.9 vs. 13.7 g/dL, P < 0.001) and relative VO2peak (24.2 vs. 27.9 ml/kg/min, P = 0.006) than healthy controls. Over time, children with SCA had smaller increases than healthy controls in VO2peak (-0.1 and +4.9 ml/kg/min, P < 0.001), Tanner stage at year 2 (15% and 66% Tanner 4, P < 0.001), and FFM (+4.0 and +6.8 kg, P = 0.02). Changes in Hgb concentration did not differ between groups (+0.03 and +0.09 g/dL, P = 1.0). After adjusting for age, sex, Tanner stage, FFM, and Hgb concentration the differences in change in VO2peak over time remained significant (P < 0.001). CONCLUSION: Children with SCA demonstrate lower relative VO2peak compared to healthy children and the difference increases over time. The difference in VO2peak trajectories between the two groups during puberty remains significant after adjusting for age, sex, FFM, Tanner stage, and Hgb concentration.
BACKGROUND: The purpose of this study was to compare longitudinal trajectories of maximal aerobic capacity in children with sickle cell anemia (SCA) and matched healthy controls, and explore whether these trajectories were associated with selected physiologic variables. PROCEDURE: Children with SCA (n = 33) and healthy controls (n = 30) matched at baseline for race, sex, Tanner stage, height, and weight completed three consecutive annual fitness assessments (VO2peak ). Data were compared between the groups at each time point and within groups over time. Change in VO2peak between the two groups over time was assessed using a linear mixed model with age, sex, fat-free mass (FFM), Tanner stage, and hemoglobin (Hgb) concentration as covariates. RESULTS: At baseline, children with SCA had significantly lower Hgb concentration (8.9 vs. 13.7 g/dL, P < 0.001) and relative VO2peak (24.2 vs. 27.9 ml/kg/min, P = 0.006) than healthy controls. Over time, children with SCA had smaller increases than healthy controls in VO2peak (-0.1 and +4.9 ml/kg/min, P < 0.001), Tanner stage at year 2 (15% and 66% Tanner 4, P < 0.001), and FFM (+4.0 and +6.8 kg, P = 0.02). Changes in Hgb concentration did not differ between groups (+0.03 and +0.09 g/dL, P = 1.0). After adjusting for age, sex, Tanner stage, FFM, and Hgb concentration the differences in change in VO2peak over time remained significant (P < 0.001). CONCLUSION:Children with SCA demonstrate lower relative VO2peak compared to healthy children and the difference increases over time. The difference in VO2peak trajectories between the two groups during puberty remains significant after adjusting for age, sex, FFM, Tanner stage, and Hgb concentration.
Authors: Christina A Geithner; Martine A Thomis; Bavo Vanden Eynde; Hermine H M Maes; Ruth J F Loos; Maarten Peeters; Albrecht L M Claessens; Robert Vlietinck; Robert M Malina; Gaston P Beunen Journal: Med Sci Sports Exerc Date: 2004-09 Impact factor: 5.411
Authors: Eduard J van Beers; Mart N van der Plas; Erfan Nur; Harm-Jan Bogaard; Reindert P van Steenwijk; Bart J Biemond; Paul Bresser Journal: Am J Hematol Date: 2014-05-16 Impact factor: 10.047
Authors: Leigh A Callahan; Kristy F Woods; George A Mensah; Leigh T Ramsey; Paule Barbeau; Bernard Gutin Journal: Am J Respir Crit Care Med Date: 2002-05-01 Impact factor: 21.405
Authors: Andrea C Buchholz; Karen M Majchrzak; Kong Y Chen; Sadhna M Shankar; Maciej S Buchowski Journal: Pediatr Res Date: 2004-05-05 Impact factor: 3.756
Authors: Elizabeth M Barden; Deborah A Kawchak; Kwaku Ohene-Frempong; Virginia A Stallings; Babette S Zemel Journal: Am J Clin Nutr Date: 2002-07 Impact factor: 7.045
Authors: Suzanne Ameringer; R K Elswick; India Sisler; Wally Smith; Thokozeni Lipato; Edmund O Acevedo Journal: J Pediatr Oncol Nurs Date: 2019-04-26 Impact factor: 1.636
Authors: Tarek Alsaied; Omar Niss; Adam W Powell; Robert J Fleck; James F Cnota; Clifford Chin; Punam Malik; Charles T Quinn; Michael D Taylor Journal: Pediatr Blood Cancer Date: 2018-05-21 Impact factor: 3.167
Authors: Kellsey N Smith; Tracy Baynard; Peter S Fischbach; Jane S Hankins; Lewis L Hsu; Peggy M Murphy; Kiri K Ness; Shlomit Radom-Aizik; Amy Tang; Robert I Liem Journal: Br J Sports Med Date: 2021-07-20 Impact factor: 18.473